Unannounced · 153 daysFiled 17 April 2026
Bonum Therapeutics, Inc. raised $26.9M
Bonum Therapeutics, Inc., a biotech company based in Seattle, WA, raised $26.9M in a new equity round, according to a filing dated 17 April 2026.
No public announcement found as of 15 September 2026, 153 days after the filing.
- Filed
- 17 April 2026
- Round
- Equity round
- Amount sold
- $26.9M
- Offering size
- $32.3M
- Investors so far
- 8
- Based in
- Seattle, WA
- Website
- bonumtx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 76% of the 845 tracked raises with an amount filed in 2026, and than 59% of the 78 in biotech.
Bonum Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Apr 2026 | New filing | $26.9M | This raise |
| 29 Nov 2022 | New filing | $45M | Another raise |
| 22 Dec 2021 | New filing | $1.19M | Another raise |
More with RiverVest on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.